Blockade of hepatic nitric oxide synthase causes insulin resistance

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 1 40-1, 1999, Pages

  Sadri, Parissa ^a   Lautt, W Wayne ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

3 morpholinosydnonimine; Diabetes; N monomethyl L arginine; N nitro L arginine methyl ester; Parasympathetic nerves

Indexed keywords

LINSIDOMINE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; DENERVATION; DIABETES MELLITUS; ENZYME ACTIVITY; HYPOTHESIS; INSULIN RESISTANCE; INSULIN RESPONSE; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; RAT;

EID: 0032806256     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.1.g101     Document Type: Article

References (30)

1. Baron, A. D., J. S. Zhu, S. Marshall, O. Irsula, G. Brechtel, and C. Keech. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E709-E715, 1995.
2. Buxton, I. L. O., D. J. Cheek, D. Eckman, D. P. Westfall, K. M. Sanders, and K. D. Keef. N-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72: 387-395, 1993.
3. Cameron, N. E., and M. A. Cotter. Effects of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetes rats. Eur. J. Clin. Invest. 25: 19-24, 1995.
4. Cameron, N. E., M. A. Cotter, and T. C. Hohman. Interactions between essential fatty acids, prostanoid, polyol pathways and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 39: 172-182, 1996.
5. Chen, Y. L., and E. J. Messina. Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H2120-H2124, 1996.
6. Cook, H. T., A. Jansen, S. Lewis, P. Largen, M. O'Donnell, D. Reaveley, and V. Cattell. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F646-F653, 1994.
7. Cyber, C. Can arginine and ornithine support gut function? Gut, Suppl. 1: 842-845, 1994.
8. Inoue, Y., B. P. Bode, D. J. Beck. A. P. Li, K. I. Bland, and W. W. Souba. Arginine transport in human liver. Ann. Surg. 218: 350-363, 1993.
9. Kihara, M., and P. A. Low. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 132: 180-185, 1995.
10. Lautt, W. W. Hepatic parasympathetic neuropathy as cause of maturity-onset diabetes? Gen. Pharmacol. 11: 343-345, 1980.
11. Lautt, W. W., X. Wang, P. Sadri, D. J. Legare, and M. P. Macedo. Rapid insulin sensitivity test (RIST). Can. J. Physiol. Pharmacol. 76: 1080-1086, 1999.
12. Macedo, M. P., and W. W. Lautt. Autoregulatory capacity in the superior mesenteric artery is attenuated by nitric oxide. Am. J. Physiol. 271 (Gastrointest. Liver Physiol. 34): G400-G404, 1996.
13. Mijare, A. H., and M. D. Jensen. Contribution of blood flow to leg glucose uptake during a mixed meal. Diabetes 44: 1165-1169, 1995.
14. Nakaki, T., and R. Kato. Beneficial circulatory effects of L-arginine. Jpn. J. Pharmacol. 66: 167-171, 1994.
15. Natali, A. Skeletal muscle blood flow and insulin action. Nutr. Metab. Cardio. Dis. 7: 105-109, 1997.
16. Natali, A., A. Q. Galvan, N. Pecorri, G. Sanna, E. Toschi, and E. Ferrannini. Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension. Hypertension 31: 632-636, 1998.
17. Omawari, N., M. Dewhurst, P. Vo, S. Mahmood, E. Stevens, and D. R. Tomlinson. Deficient nitric oxide responsible for reduced nerve blood flow in diabetes rats: effects of L-NAME, L-arginine, sodium nitroprusside, and evening primrose oil. Br. J. Pharmacol. 118: 186-190, 1996.
18. Pitre, M., A. Nadeau, and H. Bachelard. Insulin sensitivity and hemodynamic responses to insulin in Wistar-Kyoto and spontaneously hypertensive rats. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E658-E668, 1996.
19. Porter, J. P., I. G. Joshua, D. Kabith, and H. S. Bokil. Vasodilator effect of insulin on the microcirculation of the rat cremaster muscle. Life Sci. 61: 673-687, 1997.
20. Raitakari, M., P. Nuutila, U. Ruotsalainen, H. Lain, M. Teras, H. Iida, S. Makimattila, T. Utriainen, V. Oikonen, H. Sipila, M. Haaparanta, O. Solin, U. Wwegelius, J. Knuuti, and H. Yki-Jarvinen. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle. Diabetes 45: 1471-1477, 1996.
21. Rees, D. D., R. M. J. Palmer, R. Schulz, H. F. Hodson, and S. Moncada. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746-752, 1990.
22. Sadri, P., and W. W. Lautt. Blockade of nitric oxide production in the liver causes insulin resistance. Proc. West. Pharmacol. Soc. 41: 37-38, 1998.
23. Scherrer, U., D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94: 2511-2515, 1994.
24. Steinberg, H. O., G. Brechtel, A. Johnson, N. Fineberg, and A. D. Baron. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J. Clin. Invest. 94: 1172-1179, 1994.
25. Stevens, M. J. Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Diabet. Med. 12: 292-295, 1995.
26. Swislocki, A., T. Eason, and G. A. Kayen. Oral administration of nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats. Am. J. Hypertens. 8: 1009-1014, 1995.
27. Xie, H., and W. W. Lautt. Induction of insulin resistance by cholinergic blockade with atropine in the cat. J. Auton. Pharmacol. 15: 361-369, 1995.
28. Xie, H., and W. W. Lautt. Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E858-E863, 1996.
29. Xie, H., and W. W. Lautt. Insulin resistance caused by hepatic cholinergic interuption and reversed by acetylcholine administration. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E587-E592, 1996.
30. Xie, H., L. Zhu, Y. L. Zhang, D. J. Legare, and W. W. Lautt. Insulin sensitivity tested with modified euglycemic technique in cats and rats. J. Pharmacol. Toxicol. Methods 35: 77-82, 1996.